REFLECTIONS OF A PHARMACIST, ACADEMIC AND RESEARCHER IN A PIVOTAL YEAR OF CHANGE FOR THE PHARMACY PROFESSION
Dr Kate Wang, Senior Lecturer in Pharmacy, RMIT University &
Adjunct Senior Lecturer, University of Western Australia
PEOPLE IN HEALTH CARE
Filmed in Melbourne, Victoria | December 2024
Dr. Kate Wang, a Senior Lecturer in Pharmacy at RMIT University and Adjunct Senior Lecturer, University of Western Australia, has over a decade of experience in both hospital and community pharmacy settings.
Dr Wang spoke to Australian Health Journal on some of the key topics in 2024 that have been pivotal as a pharmacist, academic and researcher for the pharmacy profession.
With Australia’s ageing population projected to reach 21-23% of those over 65 by 2060, the need for effective medication management is crucial. Older adults often face multiple chronic conditions and take multiple medications, making pharmacists essential as medication experts.
Pharmacists are the most accessible healthcare professionals in Australia, allowing for regular patient interactions. This consistent contact enables them to provide ongoing monitoring and health management, highlighting the importance of expanding their scope of practice. Dr. Wang emphasises the trialing of structured prescribing for conditions like uncomplicated urinary tract infections and oral contraceptives, where timely access is vital.
Attending the PSA24 conference hosted by the Pharmaceutical Society of Australia in Sydney, she noted the collaborative efforts among healthcare professionals to address changes in scope of practice. The process requires thorough review and piloting, with a commitment to patient centred care. As the field evolves, pharmacists must adapt to new treatments and emerging health challenges, continuously striving to make a positive impact on individuals and the broader community.
-
Thyroid health into pregnancy
‘Without an adequate amount of thyroid hormone mothers can be exposed to hypertensive disorders of pregnancy, including gestational hypertension and preeclampsia or eclampsia, which affect around 10% of pregnant women and are the leading causes of maternal and neonatal mortality worldwide. Mothers who suffer from hypertensive disorders during pregnancy are at increased risk of long-term cardiovascular consequences and hypertensive disorders in subsequent pregnancies. Evidence also indicates a risk of reduced cognitive ability to their offspring.
‘Knowing if you are genetically predisposed to Hashimoto’s or Graves’ Diseases, which are both thyroid autoimmune disorders is important to be aware of, to ensure all appropriate tests are ordered. Autoimmune disorders may predispose mothers to a thyroid problem during pregnancy’, says Professor Creswell Eastman, who also serves as the ATF’s Principal Medical Advisor.
-
Priming Australia for social prescribing
Social prescribing provides support in various areas of people’s lives, leading to increased confidence, improved navigation of systems, and enhanced friendships and trust in healthcare, while communities should be designed in an age-friendly way to prevent isolation.
In Part 1 of the Models of Care on Social Prescribing, Australian Health Journal spoke to 4 people advocating for social prescribing in Australia
-
Co-design, adoption and interoperability
In October CEBIT AUSTRALIA held it’s yearly technology related conference. Australian Health Journal’s reporter Anne Dao spoke with health technology thought leaders on what needs to be consider in Co-Design, Adoption and Interoperability of technology aided healthcare delivery
